Barrett & Company’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.6K Sell
585
-7
-1% -$552 0.01% 312
2025
Q4
$48.5K Hold
592
0.02% 302
2025
Q3
$44.4K Buy
592
+1
+0.2% +$75 0.02% 317
2025
Q2
$43.8K Sell
591
-2
-0.3% -$139 0.02% 321
2025
Q1
$47.9K Sell
593
-8
-1% -$688 0.02% 276
2024
Q4
$47K Buy
601
+17
+3% +$1.45K 0.02% 280
2024
Q3
$54.8K Sell
584
-10
-2% -$839 0.02% 249
2024
Q2
$46.3K Hold
594
0.02% 269
2024
Q1
$54K Sell
594
-5
-0.8% -$416 0.03% 262
2023
Q4
$46.3K Hold
599
0.03% 259
2023
Q3
$40.8K Sell
599
-114
-16% -$8.29K 0.02% 264
2023
Q2
$57.9K Hold
713
0.03% 237
2023
Q1
$58.5K Buy
+713
New +$50.9K 0.04% 231

Other funds holding GEHC

Barrett & Company's GEHC Position: Q1 2026 in Review

Barrett & Company reduced its GE HealthCare (GEHC) stake by 1.2% in Q1 2026, selling an estimated $552 and leaving 585 shares worth $41.6K. The position accounts for 0.01% of the portfolio, ranked #312.

Barrett & Company first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $58.5K in Q1 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Barrett & Company held 585 shares of GE HealthCare worth $41.6K as of Q1 2026.
  • Barrett & Company sold 7 GE HealthCare shares in Q1 2026, an estimated $552.
  • GE HealthCare made up 0.01% of Barrett & Company's portfolio in Q1 2026, its #312 holding.
  • Barrett & Company first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Barrett & Company's GE HealthCare position peaked at $58.5K in Q1 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.